Director
Gilead Sciences, Inc.
Foster City
Atiya Taqui is currently Head of Biologics and Director in Bioanalytical Chemistry Group at Gilead Sciences, Inc. Atiya has over fifteen years of experience working in CRO, biotech and pharmaceutical industry with a focus on bioanalysis of large molecule drugs and new treatment modalities in support of PK and immunogenicity including NAb. She joined Gilead in 2020 where she supports the bioanalytical requirements for clinical studies.
Disclosure information not submitted.
FDA guidance on ADC BA: What to Measure at Different Clinical Stages
Tuesday, July 23, 2024
10:55 AM – 11:25 AM CST